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Abstract: 
Background: Excision of all visible neoplastic tissue is the goal of endoscopic mucosal resec-
tion (EMR) of colorectal laterally spreading tumors (LSTs).  Flat and fibrotic tissue can resist 
snaring. Ablation of visible polyps is associated with high recurrence rates.  Avulsion is a 
technique to continue resection when snaring fails. 
Methods: We retrospectively analyzed colonic EMRs of 564 consecutive referred polyps be-
tween 2015 and 2017. Hot avulsion was used when snaring was unsuccessful. Polyps treated 
with and without avulsion were compared. 
Results: Hot avulsion was used in 20.9% (n=112) of all resected lesions. The recurrence rates 
on follow up colonoscopy were 17.52% in avulsion group versus 16.02% in the non-avulsion 
group (p= 0.76). Hot avulsion was associated with a trend toward higher rates of delayed 
hemorrhage (5.35% vs 2.58%; p=0.15) and post-coagulation syndrome (1.8% vs 0.47%; 
p=0.15), but polyps treated with any avulsion were larger than those in which no avulsion 
was used (p=<0.001). There were an insufficient number of adverse events to perform a 
multivariable analysis testing the effects of avulsion, size, and location on the risk of overall 
adverse events. 
Conclusion: Unlike previous reports of using argon plasma coagulation to treat visible polyp 
during EMR, hot avulsion of visible/fibrotic neoplasia was associated with similar EMR effica-
cy compared with cases that did not require hot avulsion.  The safety profile of hot avulsion 
appears acceptable. 
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Introduction 
Endoscopic mucosal resection (EMR) is a widely used approach to resection of lateral spread-
ing tumors (LSTs) during colonoscopy.  EMR consists fundamentally of submucosal injection 
followed by snare resection, which is often performed piecemeal in the cases of larger LSTs.  
Compared with endoscopic submucosal dissection (ESD), EMR has a high recurrence rate, and 
is more likely to result in adjuvant surgical resection when superficial submucosally invasive 
cancer is present. 1 However, EMR has a substantially lower risk of perforation compared 
with ESD, is quicker to perform, and has similar long-term outcomes. 1 
 Although snare resection (piecemeal or en bloc) of the entire LST is the goal of 
EMR, it is not uncommon for some portion of an LST to resist attempts at snare resec-
tion, usually because of flat shape or submucosal fibrosis. In the past, flat or fibrotic 
neoplastic tissue that resisted snaring was usually treated with an ablative technique, 
most commonly using argon plasma coagulation (APC). 2,3  However, ablation to treat 
visible residual neoplastic tissue that has resisted snaring is associated with an in-
creased recurrence rate at follow-up. 4,5 This finding suggests that ablation is funda-
mentally inferior to resection, probably because endoscopists performing ablation 
cannot be certain whether the thermal injury has been deep enough to destroy all 
neoplastic tissue. 6,7  Logically, continued resection in the same submucosal plane 8 
developed by snaring seems likely to be more effective than ablation.  
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 Recent studies found that the process of continuing resection in flat or fibrotic 
polyp tissue that has resisted snaring can be achieved using avulsion. In avulsion, flat 
or fibrotic tissue is grasped with a forceps and pulled off. The grasping capacity of 
forceps enables the success of avulsion in removal of tissue that resists capture with a 
snare. 
 There is some controversy as to whether avulsion should be performed without 
electrocautery (cold avulsion) or with electrocautery (performed with hot forceps and 
called hot avulsion).  Hot forceps are no longer used or advocated for the removal of 
diminutive polyps, because they are ineffective 7 and have been associated with deep 
thermal injury. 9  Additionally, hot forceps removal of diminutive polyps generally 
used forced coagulation current, and thermal injury likely accounts for all hot forceps 
related adverse events. 9,10  Advocates of hot avulsion (vs cold avulsion) during EMR of-
ten cite lack of bleeding with hot compared with cold avulsion, and the clean separa-
tion that occurs in the submucosal plane with the hot technique. Hot avulsion as part 
of EMR is often performed using a low voltage current to reduce the risk of thermal 
injury.  Advocates of cold avulsion 11,12 cite concern about the risk of grasping and in-
juring the muscularis propria during hot avulsion. Some endoscopists follow cold avul-
sion with soft coagulation treatment of the avulsion defect using the snare tip. 
Whether snare tip soft coagulation of the defect is safer than hot avulsion using low 
voltage current is unknown.   
No randomized controlled trials of hot vs. cold avulsion have been performed. 
In this report we describe our experience with hot avulsion in the performance of EMR 
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in a tertiary referral center for resection of complex polyps.  We describe the efficacy 
of hot avulsion and adverse event rate of EMRs performed with versus without hot 
avulsion. 
Methods 
 We evaluated a quality database of EMRs performed by DKR.  All lesions were 
referred by other endoscopists for resection. The study interval was January 2015 
through June 2017, and the beginning of the study interval corresponds to when DKR 
began to use hot avulsion to complete selected EMRs.  Permission to review the data-
base for the study was granted by the Institutional Review Board at Indiana University 
on May 30, 2018. 
 All resected lesions were flat or sessile, and nearly all had sufficient diameter 
to be called lateral spreading tumors. For most lesions, the submucosal injection fluid 
was hydroxyethyl starch, but Eleview (Aries Pharmaceuticals, San Diego, Calif) was 
used in some cases.  The maximum polyp diameter was measured in all cases using a 
stiff snare of 15 or 20 mm diameter.  In all cases lesion size was recorded as the size 
measured at our center and not as the size measured or estimated by the referring 
physician.  Although most previous reports from our database have involved EMR of le-
sions ≥20 mm in size, in this report we include all referred lesions during the study in-
terval.  After submucosal injection, polyps were typically resected using stiff snares 
20, 15, or 10 mm size (Boston Captivator 2, Boston Scientific, Nadick, Mass).  If there 
were fibrotic areas or areas that were flat or resisted snaring, avulsion was performed 
using Boston Scientific hot forceps.  The technique for avulsion was to grasp the re-
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
  
6 
sidual polyp tissue firmly with the hot forceps, tent, and apply electrocautery using 
Endocut I (3-1-3 setting; Erbe, Erlangen, Germany) and mechanically pull the tissue 
off.  If any part of the lesion was removed by avulsion, the lesion was designated an 
avulsion EMR.  If the entire lesion was removed by snare resection, the lesion was 
termed a non-avulsion lesion. During part of the interval, snare tip soft coagulation 
(STSC) was used to ablate the normal-appearing tissue at the rim of the EMR defect of 
both avulsion and non-avulsion lesions. Many of the defects were closed completely or 
partially with hemostatic clips.  
 Patients were generally scheduled for follow-up at 6- to 12-month intervals, 
depending on the size of the lesion and whether the EMR was performed piecemeal or 
en bloc.  At follow-up, a residual polyp was deemed to be present if magnified inspec-
tion (Olympus narrow-band imaging on close focus) demonstrated residual polyp tissue 
(regardless of whether residual tissue was confirmed by pathology), or if the EMR scar 
appeared normal but random biopsy specimens of the scar using cold forceps demon-
strated residual polyp histologically.   
 Patients were called within 30 days after EMR to identify adverse events. De-
layed hemorrhage was defined as bleeding that occurred after discharge from the en-
doscopy unit and which required repeat colonoscopy, transfusion, or hospitalization. 
Post-coagulation syndrome was defined as abdominal pain requiring hospitalization 
and/or antibiotic treatment, without radiographic evidence of perforation.  
 Rates of residual polyp, delayed hemorrhage, and post-coagulation syndrome 
were compared by chi-square. There were an insufficient number of adverse events to 
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perform a multivariable analysis of whether avulsion predicted delayed hemorrhage 
independent of polyp size and location.  Mean polyp size and location in avulsed vs. 
non-avulsed polyps were compared by t tests and chi square or Fischer exact test.  
The study was observational, and no sample size calculation was made.   
 
  
Results 
  
 During the study interval, there were 564 lesions referred for EMR in 506 pa-
tients. 27 lesions were deemed unresectable and so were excluded from analysis giv-
ing a total of 537 lesions (95.2% of all referred lesions) in 482 patients. The patient 
population consisted of 51.45% (n= 248) females and males (n=234). The mean age 
was 64.62 years (ranging from 34-91). The sizes of lesions in the study as measured at 
our center were <10 mm (n=15/537; 2.8% of all lesions), 10 to 19 mm (n=150; 27.93%), 
20 to 29 mm (n=198; 36.87%), 30 to 39 mm (n=97; 18.06%), 40 to 49 mm (n=33; 
6.15%), 50 to 69 mm (n=35; 6.52%), 70 to 100 mm (n=9;1.68%). 
 
 Hot avulsion was used in 20.9% (n=112) of all resected lesions.  Hot avulsion 
was used more commonly in adenomas (24.9%; n= 95/381) than serrated lesions  (11.% 
(n= 17/154; p = 0.003). The use of hot avulsion increased with lesion size (Table 1).  
There were 2 lesions that were mucosal prolapse histologically, and neither required 
avulsion.  Table 2 shows the overall size distribution and colonic location of the EMRs 
using avulsion vs no avulsion.  There was no association of colonic location with the 
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use of avulsion, but EMRs in which avulsion was used were larger than EMRs not in-
volving avulsion (P < 0.001).   
  A substantial fraction of lesions referred for EMR were ≤20 mm in size. All le-
sions <10 mm in size had been either partially resected by the referring doctor, or it 
was noted they could not be reached or accessed adequately for polypectomy.   
A total of 409 lesions in 364 patients underwent their first follow-up examination at 
our center. Despite their larger size, the risk of residual polyp at first follow-up was 
similar in the avulsion 17.5% (n=17/97) and non-avulsion groups 16.0% (n=50/312); P= 
0.76. (Table 1) In the avulsion group, 12 recurrences were associated with 
endoscopically visible recurrent polyp that was verified by pathology, 2 were 
endoscopically visible but not verified by pathology (pathology was negative likely 
because of tissue destruction during excision), and 3 cases had no endoscopically 
visible recurrence, but cold biopsies of the resection site demonstrated residual 
polyp. In the non-avulsion group, 37 recurrences were endoscopically visible and 
verified by pathology, 8 were endoscopically visible and not verified by pathology and 
5 cases had no visible endoscopic recurrence but were path positive.  
The risk of delayed post-polypectomy hemorrhage and post-polypectomy co-
agulation syndrome were both numerically higher in patients who underwent EMR in-
volving avulsion (Table 2). However, absolute rates of adverse event in patients with 
EMRs involving avulsion were low, and as noted above EMRs using avulsion involved 
larger lesions than the non-avulsion lesions, and numerically were more common in 
the right colon. In the avulsion group 81 (72.3%) of resection sites underwent com-
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plete and 8 (7.1%) underwent partial prophylactic clipping. In the non-avulsion group 
274 (64.5%) lesions underwent complete and 13 (3.1%) partial clip closure. There was 
no difference between the groups in the fraction of resection sites to which clips 
were applied (p= 0.32).  All 17 bleeds in the study (Table 2) were from proximal colon 
lesions.  
There was an insufficient number of adverse events to perform a multivariable 
analysis testing whether avulsion, polyp size, and polyp location were independent 
predictors of adverse events. There were no perforations. 
 
 
Discussion 
 In this report we describe our experience using hot avulsion to perform endo-
scopic mucosal resection (EMR) in 537 nonpedunculated lesions undergoing endoscopic 
resection after referral to our center.  
 We found avulsion to be necessary in 20.9% of referred polyps that underwent 
resection.  The remainder of the lesions were removed entirely by snare resection. 
Relative to published experience with APC, 4,5 avulsion was a successful method of 
continued treatment of residual polyp after snare resection was exhausted. Thus, un-
like the published experience with APC, 4,5 avulsion was not associated with an in-
creased risk of residual polyp at first follow-up compared with lesions removed with-
out avulsion.  
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 One concern regarding the use of hot avulsion, compared with cold avulsion, is 
the potential for an increased risk of thermal injury when avulsion is performed with 
electrocautery. 10,13  In order to reduce the risk of thermal injury, we performed avul-
sion using the low voltage Endocut I current, rather than the higher voltage Endocut Q 
current recommended for snaring. We did see a numerically higher rate of delayed 
hemorrhage and post-coagulation syndrome in patients whose lesions were removed 
with techniques including hot avulsion. However, the absolute risk of delayed hemor-
rhage and post-coagulation syndrome were both low, and the polyps in the avulsion 
group were significantly larger than those in the non-avulsion lesions, and numerically 
more likely to be located in the proximal colon. Polyp size is a known risk factor for 
adverse events, particularly for delayed hemorrhage, as is proximal colon location. 
14,15  Thus, our data suggest that hot avulsion has an acceptable safety profile in the 
performance of EMR.  Importantly, no perforations were noted with the use of hot 
avulsion. 
 Advantages of hot avulsion compared with cold avulsion include an absence of 
immediate bleeding in most cases, allowing easy visualization of separation of the re-
tained polyp tissue, which typically occurs in the same submucosal plane that the 
snare resection had created (Video 1-3; Figure 1). Hot avulsion leaves the endoscopic 
field dry and, in most cases, there is no need to apply snare tip soft coagulation to 
stop immediate oozing as some practitioners use after cold avulsion.   
 The technique for hot avulsion is straightforward and involves firmly grasping 
the flat or fibrotic residual polyp, tenting to move the forceps away from the muscle 
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layer, application of low voltage current, and nearly immediately pulling the tissue 
off mechanically (Video 1-3).  
 In a number of previous studies on polyp resection from our center, we report-
ed only non-pedunculated lesions at least 20 mm in size.16-20 However, in the current 
study it seemed reasonable to include all referred polyps. These data show that a 
substantial fraction of nonpedunculated colorectal lesions referred to a tertiary cen-
ter are <20 mm in maximum dimension. This finding is consistent with our previous 
anecdotal experience and reports from others.21 
 Practitioners are sometimes confused by the assertion that APC applied to re-
sidual polyp results in a higher recurrence rate, whereas APC applied to the normal 
appearing edge after complete endoscopic resection of the polyp results in a lower 
recurrence rate.2,22,23 However, ablating visible residual polyp, which has a negative 
impact on recurrence rates, is a completely separate and different concept from ab-
lation of the normal appearing tissue at the rim of the EMR defect after resection by 
snaring (and avulsion if needed) of all visible polyp tissue has been completed.  
Treatment of the normal rim to reduce recurrence rates is now performed by most 
experts using the snare tip in the soft coagulation mode,24-26 which is effective, and 
considerably less costly than APC. Thus, the roles of APC in EMR have been almost 
completely supplanted, including by avulsion to resect visible residual polyp, and 
STCS to treat the normal appearing rim of the EMR defect after resection has been 
completed.   
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 Limitations of this study include its retrospective nature, though the database 
was constructed prospectively and our methods for collecting cases allow us to be 
certain that all referred cases were included.  Also, we did not systematically collect 
data on factors that could increase submucosal fibrosis, such as previous partial re-
section, biopsy, and placement of tattoos that extended under the lesion. These fac-
tors could have an important influence on the need for avulsion during EMR.  
 In summary, we have demonstrated that hot avulsion has an acceptable safety 
profile and is an effective adjunct to snare resection during the process of EMR of se-
lected lateral spreading tumors that have flat or fibrotic tissue resistant to snaring.  A 
randomized controlled trial to compare the efficacy, safety, and efficiency of hot to 
cold avulsion appears warranted. 
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Table 1. Use of avulsion in lesions referred for resection according to lesion size 
 
Lesion size                Number of lesions               Number with avulsion used (%) 
< 10 mm                             15                                          0 (0) 
11-19 mm                           150                                       13 (8.7)                         
20-29 mm                           198                                        41 (20.7) 
30-39 mm                             97                                        33 (34.0) 
40-49 mm                             33                                        14 (42.4) 
50-69 mm                             35                                         7 (20) 
70-100 mm                            9                                          4 (44.4) 
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Table 2. Comparison of the avulsion and non-avulsion lesions   
 
Avulsion group Non-avulsion group P value 
No. of lesions 112 425 
 
 
Size of polyp, Mean (+ 
SD) 
 
30.55 mm (SD +12.70) 
 
24.85 mm (SD +13.11) 
 
      
<0.001 
Location of polyps 
           Right sided 
           Left sided 
 
98 (87.5%) 
14 (12.5%) 
 
341 (80.24%) 
84   (19.76%) 
 
 
0.76 
              
Adverse events (total) 
    
          
Number with delayed  
bleeding 
 
           Mean size of polyp asso-
ciated with bleeding event  (+ SD) 
 
            
     
 
     
 
          
 
 
 
 
Postcoagulation syndrome 
 
 
 
6 (5.35%) 
 
 
44.16 mm (SD + 21.07) 
 
 
 
 
 
 
 
 
 
 
 
 
2 (1.8%) 
 
 
 
11  (2.58%) 
 
 
31 mm (SD + 11.57) 
 
 
 
 
 
 
 
 
 
 
 
 
2 (0.47%) 
 
 
   
0.15      
 
 
0.20     
 
 
          
         
 
     
      
   
      
 
 
 
 
0.15 
     
Recurrence (17/97) 17.52%  (50/312) 16.02% 0.76 
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Figure legend 1. Avulsion of flat portion of a lateral spreading tumor. 1A, Residual flat 
lesion in center of an EMR defect. 1B, Placement of hot forceps. 1C, Grasping of tis-
sue (1D) lifting (1E) defect shows separation of the grasped tissue in the submucosal 
resection plane. The submucosal resection plane where the grasped tissue was re-
moved is designated by the arrow. 1F, More tissue grasped followed by (1G) lifting or 
tenting of tissue before cautery and pulling tissue off. 1H, Defect after avulsion of the 
flat tissue in 4 bites. 
 
Videos 1-3.  Edited videos of hot avulsion of 3 different lateral spreading tumors 
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Acronyms 
EMR: endoscopic mucosal resection 
LST: laterally spreading tumors 
ESD: endoscopic submucosal dissection 
APC: argon plasma coagulation 
Vs: versus 
DKR: Douglas K Rex MD 
CA: California 
MA: Massachusetts 
STSC: snare tip soft coagulation 
Mm: millimeters 
No: Number 
